Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Central Control of Feeding Behavior by the Secretin, PACAP, and Glucagon Family of Peptides.

Sekar R, Wang L, Chow BK.

Front Endocrinol (Lausanne). 2017 Feb 7;8:18. doi: 10.3389/fendo.2017.00018. eCollection 2017. Review.

2.

Type 2 diabetes, bariatric surgery and the risk of subsequent gestational diabetes.

Steven S, Woodcock S, Small PK, Taylor R.

Obstet Med. 2011 Dec;4(4):171-3. doi: 10.1258/om.2011.110020. Epub 2011 Sep 15.

3.

Changes in levels of selected incretins and appetite-controlling hormones following surgical treatment for morbid obesity.

Major P, Matłok M, Pędziwiatr M, Migaczewski M, Zub-Pokrowiecka A, Radkowiak D, Winiarski M, Zychowicz A, Fedak D, Budzyński A.

Wideochir Inne Tech Maloinwazyjne. 2015 Sep;10(3):458-65. doi: 10.5114/wiitm.2015.54003. Epub 2015 Sep 11.

4.

Insulin Sensitivity and β-Cell Function Improve after Gastric Bypass in Severely Obese Adolescents.

Inge TH, Prigeon RL, Elder DA, Jenkins TM, Cohen RM, Xanthakos SA, Benoit SC, Dolan LM, Daniels SR, D'Alessio DA.

J Pediatr. 2015 Nov;167(5):1042-8.e1. doi: 10.1016/j.jpeds.2015.08.020. Epub 2015 Sep 9.

5.

Effect of bariatric surgery on humoral control of metabolic derangements in obese patients with type 2 diabetes mellitus: How it works.

Cetinkunar S, Erdem H, Aktimur R, Sozen S.

World J Clin Cases. 2015 Jun 16;3(6):504-9. doi: 10.12998/wjcc.v3.i6.504. Review.

6.

Preoperative β-cell function in patients with type 2 diabetes is important for the outcome of Roux-en-Y gastric bypass surgery.

Lund MT, Hansen M, Skaaby S, Dalby S, Støckel M, Floyd AK, Bech K, Helge JW, Holst JJ, Dela F.

J Physiol. 2015 Jul 15;593(14):3123-33. doi: 10.1113/JP270264. Epub 2015 Jun 17.

7.

Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?

Finelli C, Padula MC, Martelli G, Tarantino G.

World J Gastroenterol. 2014 Nov 28;20(44):16649-64. doi: 10.3748/wjg.v20.i44.16649. Review.

8.

Ability of GLP-1 to decrease food intake is dependent on nutritional status.

Ronveaux CC, de Lartigue G, Raybould HE.

Physiol Behav. 2014 Aug;135:222-9. doi: 10.1016/j.physbeh.2014.06.015. Epub 2014 Jun 21.

9.

Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose.

Hayes MR, Mietlicki-Baase EG, Kanoski SE, De Jonghe BC.

Annu Rev Nutr. 2014;34:237-60. doi: 10.1146/annurev-nutr-071812-161201. Epub 2014 Apr 10.

10.

Long-term diabetic response to gastric bypass.

Davies SW, Efird JT, Guidry CA, Penn RI, Sawyer RG, Schirmer BD, Hallowell PT.

J Surg Res. 2014 Aug;190(2):498-503. doi: 10.1016/j.jss.2014.01.047. Epub 2014 Jan 29.

11.

Oligopeptides stimulate glucagon-like peptide-1 secretion in mice through proton-coupled uptake and the calcium-sensing receptor.

Diakogiannaki E, Pais R, Tolhurst G, Parker HE, Horscroft J, Rauscher B, Zietek T, Daniel H, Gribble FM, Reimann F.

Diabetologia. 2013 Dec;56(12):2688-96. doi: 10.1007/s00125-013-3037-3. Epub 2013 Sep 18.

12.

Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.

Jørgensen NB, Dirksen C, Bojsen-Møller KN, Jacobsen SH, Worm D, Hansen DL, Kristiansen VB, Naver L, Madsbad S, Holst JJ.

Diabetes. 2013 Sep;62(9):3044-52. doi: 10.2337/db13-0022. Epub 2013 May 6.

13.

Effects of gastrogastric fistula repair on weight loss and gut hormone levels.

O'Brien CS, Wang G, McGinty J, Agénor KK, Dutia R, Colarusso A, Park K, Koshy N, Laferrère B.

Obes Surg. 2013 Aug;23(8):1294-301. doi: 10.1007/s11695-013-0917-z.

14.

Gastrointestinal hormones and bariatric surgery-induced weight loss.

Ionut V, Burch M, Youdim A, Bergman RN.

Obesity (Silver Spring). 2013 Jun;21(6):1093-103. doi: 10.1002/oby.20364. Review.

15.

Effects of bariatric surgery on glucose homeostasis and type 2 diabetes.

Bradley D, Magkos F, Klein S.

Gastroenterology. 2012 Oct;143(4):897-912. doi: 10.1053/j.gastro.2012.07.114. Epub 2012 Aug 8. Review.

16.

Role of Gut-Related Peptides and Other Hormones in the Amelioration of Type 2 Diabetes after Roux-en-Y Gastric Bypass Surgery.

Hage MP, Safadi B, Salti I, Nasrallah M.

ISRN Endocrinol. 2012;2012:504756. doi: 10.5402/2012/504756. Epub 2012 May 7.

17.

Mechanisms responsible for excess weight loss after bariatric surgery.

Ionut V, Bergman RN.

J Diabetes Sci Technol. 2011 Sep 1;5(5):1263-82. Review.

18.

Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol.

Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R.

Diabetologia. 2011 Oct;54(10):2506-14. doi: 10.1007/s00125-011-2204-7. Epub 2011 Jun 9.

19.

Resolution of diabetes mellitus by ileal transposition compared with biliopancreatic diversion in a nonobese animal model of type 2 diabetes.

Zhang GY, Wang TT, Cheng ZQ, Feng JB, Hu SY.

Can J Surg. 2011 Aug;54(4):243-51. doi: 10.1503/cjs.044209.

20.

Comparison of glucostatic parameters after hypocaloric diet or bariatric surgery and equivalent weight loss.

Plum L, Ahmed L, Febres G, Bessler M, Inabnet W, Kunreuther E, McMahon DJ, Korner J.

Obesity (Silver Spring). 2011 Nov;19(11):2149-57. doi: 10.1038/oby.2011.134. Epub 2011 May 19.

Supplemental Content

Support Center